Assessment of cognitive function in patients with essential hypertension treated with lercanidipine

Abstract

The third-generation calcium channel antagonist, lercanidipine, improved cognitive function after 6 months of treatment especially in patients with good BP control, suggesting that improvements in cognitive function may be associated with a decrease in BP.